Clinical Trials Directory

Trials / Unknown

UnknownNCT01013636

Human Anaplasmosis in Eastern France

Epidemiology and Clinical Presentation of Human Anaplasmosis in Eastern France

Status
Unknown
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
10 Years
Healthy volunteers
Not accepted

Summary

Anaplasmosis is a tick-borne transmitted infection. Its clinical expression include fever, cytopenia and hepatitis.This infection was initially described in United States. In Europe, its epidemiology is not well known. Some isolated cases have been diagnosed in several country, were the tick Ixodes ricinus is known to transmitted another infection :the Lyme borreliosis.The purpose of our study is to look systematically for Anaplasmosis, in patient living in Eastern France, and presenting with compatible clinical symptoms using a new diagnosis tool : PCR in blood samples. So we will have new data about epidemiology in our country and the clinical symptoms that are associated with Anaplasmosis.

Conditions

Interventions

TypeNameDescription
PROCEDUREBlood sampling* Anaplasma diagnosis test : serology and PCR * If presence of Anaplasma infection, proposition of treatment with doxycylin 200 mg once-a-day during 10 days

Timeline

Start date
2009-11-01
Primary completion
2012-04-01
First posted
2009-11-16
Last updated
2011-08-30

Locations

12 sites across 1 country: France

Source: ClinicalTrials.gov record NCT01013636. Inclusion in this directory is not an endorsement.